Filing Details
- Accession Number:
- 0000929638-25-001870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-14 16:36:04
- Reporting Period:
- 2025-05-12
- Filing Date:
- 2025-05-14
- Accepted Time:
- 2025-05-14 16:36:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1637715 | Onkure Therapeutics Inc. | OKUR | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1583977 | Cormorant Asset Management, Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No | |
1599214 | Bihua Chen | C/O Cormorant Asset Management, Lp 200 Clarendon Street, 52Nd Floor Boston MA 02116 | No | No | No | No | |
1618442 | Cormorant Global Healthcare Master Fund, Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No | |
1817320 | Cormorant Private Healthcare Fund Iii Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No | |
1871297 | Cormorant Private Healthcare Fund Iv Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No | |
1969296 | Cormorant Private Healthcare Fund V Lp | 200 Clarendon Street 52Nd Floor Boston MA 02116 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2025-05-12 | 24,300 | $1.99 | 1,813,439 | No | 4 | S | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnotes |
Footnotes
- Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV") and Cormorant Private Healthcare Fund V, LP ("Fund V"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.
- Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
- Represents (i) 429,934 shares of Class A Common Stock beneficially owned by the Master Fund, (ii) 1,099,451 shares of Class A Common Stock beneficially owned by Fund III, (iii) 234,125 shares of Class A Common Stock beneficially owned by Fund IV, and (iv) 49,929 shares of Class A Common Stock beneficially owned by Fund V.